Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
Are you prone to missing doses of your antiretroviral drugs? If so, a Norvir-boosted protease inhibitor may be a good choice for you. A new Canadian study of 1,630 HIVers examining the links among treatment failure, specific anti-HIV drugs, and adherence has found that adherence of less than 95% significantly raised the risk of treatment failure for people taking an unboosted protease inhibitor or nonnucleoside drugs. But there was no increased risk seen among people on boosted protease inhibitor regimens. Norvir-boosted protease inhibitors remain at therapeutic levels in the body longer than other anti-HIV drugs, making an occasional delayed or missed dose unlikely to result in a loss of virological control and the emergence of drug resistance, according to the researchers. 'For individuals at high risk of suboptimal adherence, using boosted protease inhibitor'based regimens may achieve higher effectiveness rates,' they conclude.
Recommended Stories for You
From our Sponsors
Most Popular
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
Grindr is reminding us why jockstraps are so sexy and iconic
May 02 2025 5:36 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
Plus: Featured Video
More Videos
0 seconds of 3 minutes, 18 secondsVolume 0%
Press shift question mark to access a list of keyboard shortcuts
Keyboard Shortcuts
Shortcuts Open/Close/ or ?
Play/PauseSPACE
Increase Volume↑
Decrease Volume↓
Seek Forward→
Seek Backward←
Captions On/Offc
Fullscreen/Exit Fullscreenf
Mute/Unmutem
Decrease Caption Size-
Increase Caption Size+ or =
Seek %0-9
Next Up
Pride Today | Andrew Mitch is Showing Plenty of Skin as an Out and Proud Gay Country Singer
01:41
Copied
Live
00:00
03:18
03:18
Latest Stories
The Talk: Starting the conversation
6 hours ago
BREAKING: Supreme Court rules to save free access to preventive care, including PrEP
June 27 2025 10:32 AM
HRC holds 'die-in' to protest Trump health care cuts
April 28 2025 2:11 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
“I felt like a butterfly”: Niko Flowers on reclaiming life with HIV
July 23 2025 12:22 PM
1985: the year the AIDS crisis finally broke through the silence
June 26 2025 11:24 AM
Trump admin guts $258 million in funding for HIV vaccine research
June 03 2025 3:47 PM
Two right-wing Supreme Court justices signal they may uphold access to PrEP and more
April 21 2025 4:10 PM
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
Dancer. Healer. Survivor. DéShaun Armbrister is all of the above
July 02 2025 8:23 PM
VIDEO: A man living with HIV discusses his journey to fatherhood
June 10 2025 4:58 PM
500,000 Children at Risk: PEPFAR Funding Crisis
April 08 2025 3:51 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM